These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 33156381)

  • 1. Impact of late administration of corticosteroids in COVID-19 ARDS.
    Mongardon N; Piagnerelli M; Grimaldi D; Perrot B; Lascarrou JB;
    Intensive Care Med; 2021 Jan; 47(1):110-112. PubMed ID: 33156381
    [No Abstract]   [Full Text] [Related]  

  • 2. Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome.
    Liu J; Zhang S; Dong X; Li Z; Xu Q; Feng H; Cai J; Huang S; Guo J; Zhang L; Chen Y; Zhu W; Du H; Liu Y; Wang T; Chen L; Wen Z; Annane D; Qu J; Chen D
    J Clin Invest; 2020 Dec; 130(12):6417-6428. PubMed ID: 33141117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease.
    Taboada M; Caruezo V; Naveira A; Atanassoff PG
    J Clin Anesth; 2020 Nov; 66():109926. PubMed ID: 32474331
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome.
    Perlin DS; Neil GA; Anderson C; Zafir-Lavie I; Raines S; Ware CF; Wilkins HJ
    J Clin Invest; 2022 Feb; 132(3):. PubMed ID: 34871182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis.
    Tang BM; Craig JC; Eslick GD; Seppelt I; McLean AS
    Crit Care Med; 2009 May; 37(5):1594-603. PubMed ID: 19325471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latent Class Analysis Reveals COVID-19-related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids.
    Sinha P; Furfaro D; Cummings MJ; Abrams D; Delucchi K; Maddali MV; He J; Thompson A; Murn M; Fountain J; Rosen A; Robbins-Juarez SY; Adan MA; Satish T; Madhavan M; Gupta A; Lyashchenko AK; Agerstrand C; Yip NH; Burkart KM; Beitler JR; Baldwin MR; Calfee CS; Brodie D; O'Donnell MR
    Am J Respir Crit Care Med; 2021 Dec; 204(11):1274-1285. PubMed ID: 34543591
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic steroids in patients with COVID-19: pros and contras, an endocrinological point of view.
    Berton AM; Prencipe N; Giordano R; Ghigo E; Grottoli S
    J Endocrinol Invest; 2021 Apr; 44(4):873-875. PubMed ID: 32514902
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of pulse-dose and high-dose corticosteroids with no corticosteroid treatment for COVID-19 pneumonia in the intensive care unit.
    Yaqoob H; Greenberg D; Hwang F; Lee C; Vernik D; Manglani R; Wang Z; Murad MH; Chandy D; Epelbaum O
    J Med Virol; 2022 Jan; 94(1):349-356. PubMed ID: 34542192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study.
    Monreal E; Sainz de la Maza S; Natera-Villalba E; Beltrán-Corbellini Á; Rodríguez-Jorge F; Fernández-Velasco JI; Walo-Delgado P; Muriel A; Zamora J; Alonso-Canovas A; Fortún J; Manzano L; Montero-Errasquín B; Costa-Frossard L; Masjuan J; Villar LM;
    Eur J Clin Microbiol Infect Dis; 2021 Apr; 40(4):761-769. PubMed ID: 33083917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corticosteroid administration for acute respiratory distress syndrome : therapeutic option?].
    Möhnle P; Briegel J
    Anaesthesist; 2012 Apr; 61(4):344-53. PubMed ID: 22526745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential benefits of precise corticosteroids therapy for severe 2019-nCoV pneumonia.
    Zhou W; Liu Y; Tian D; Wang C; Wang S; Cheng J; Hu M; Fang M; Gao Y
    Signal Transduct Target Ther; 2020 Feb; 5(1):18. PubMed ID: 32296012
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of corticosteroid treatment for hospitalized patients with severe COVID-19: a multicentre study.
    Bartoletti M; Marconi L; Scudeller L; Pancaldi L; Tedeschi S; Giannella M; Rinaldi M; Bussini L; Valentini I; Ferravante AF; Potalivo A; Marchionni E; Fornaro G; Pascale R; Pasquini Z; Puoti M; Merli M; Barchiesi F; Volpato F; Rubin A; Saracino A; Tonetti T; Gaibani P; Ranieri VM; Viale P; Cristini F;
    Clin Microbiol Infect; 2021 Jan; 27(1):105-111. PubMed ID: 32971254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Case Report for Using Methylprednisolone for Severe ARDS Caused by SARS-CoV-2 Delta Variant in a Pediatric Patient With Lennox-Gastaut Syndrome.
    Park E; You J
    J Korean Med Sci; 2022 Mar; 37(10):e82. PubMed ID: 35289141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the early short-course corticosteroids treatment in ARDS caused by COVID-19: A single-center, retrospective analysis.
    Boglione L; Olivieri C; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Biffi S; Borrè S
    Adv Med Sci; 2021 Sep; 66(2):262-268. PubMed ID: 34022675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID-19): A systematic review.
    Landolf KM; Lemieux SM; Rose C; Johnston JP; Adams CD; Altshuler J; Berger K; Dixit D; Effendi MK; Heavner MS; Lemieux D; Littlefield AJ; Nei AM; Owusu KA; Rinehart M; Robbins B; Rouse GE; Thompson Bastin ML
    Pharmacotherapy; 2022 Jan; 42(1):71-90. PubMed ID: 34662448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticosteroids in adult respiratory distress syndrome - an inconvenient truth?
    Shulman R; Montanari C; Pinheiro I; Longobardo A; Benhalm S; Polhill S; Singer M; Bellingan G; Arulkumaran N
    Int J Pharm Pract; 2021 Dec; 29(6):642-644. PubMed ID: 34469546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
    Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
    CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroids in H1N1, non-viral, and COVID-19 ARDS.
    Kwon KE; Jung SY; Baek MS; Kim WY
    Intensive Care Med; 2022 Dec; 48(12):1809-1811. PubMed ID: 36175558
    [No Abstract]   [Full Text] [Related]  

  • 19. COVID-19 in Lung Transplant Recipients: 2 Cases With Acute Respiratory Distress Syndrome Successfully Treated With High-Dose Corticosteroids.
    Brugiere O; Neuville M; Le Balch P; Le Tulzo Y; Brun AL; Hamid A; Beaumont L; Roux A; Jouneau S; Parquin F
    Exp Clin Transplant; 2021 Jul; 19(7):744-748. PubMed ID: 34085913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review of the Evidence for Corticosteroids in COVID-19.
    Johns M; George S; Taburyanskaya M; Poon YK
    J Pharm Pract; 2022 Aug; 35(4):626-637. PubMed ID: 33719698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.